Fauci calls Johnson & Johnson pause a 'very strong argument' for the safety of COVID-19 vaccines

Dr. Anthony Fauci on Tuesday addressed the FDA and the CDC's decision to recommend a pause of Johnson & Johnson's COVID-19 vaccine, arguing the move was not made "too quickly" and ultimately shows "how seriously we take safety."
Fauci, President Biden's chief medical adviser, at a White House press conference spoke about the health agencies' recommendation that use of the Johnson & Johnson COVID-19 vaccine be paused while officials look into six blood clotting cases. He stressed that "this is a very rare event" given that 6.8 million doses of the Johnson & Johnson vaccine have been administered in the United States, though he argued that officials weren't "pulling the trigger too quickly" with the pause.
"This is an unusual occurrence of a serious, adverse event that you want to make sure, before you go forward, you investigate it thoroughly, and that's exactly what they're doing," Fauci said. "They're pausing so that they can look at it more carefully."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The move to pause the Johnson & Johnson vaccine over such a rare occurrence prompted some criticism, though, as well as concerns that it could lead to greater vaccine hesitancy. But Fauci argued it should only make Americans more confident in the process.
"The fact that a pause was done I think just is a testimony to how seriously we take safety, and why we have an FDA and a CDC that looks at this very carefully and hopefully will resolve it pretty soon, within days to weeks," Fauci said. "...So I think it's a very strong argument for safety, actually."
Fauci also stressed that there have been "no red flag signals" from the Moderna or Pfizer vaccines even though they have already been administered to tens of millions of Americans, which shows that "you're dealing with a really safe vaccine."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
US foodies brace for tariff war
Under The Radar Shoppers stocking up on imported olive oil, maple syrup and European wine as price hikes loom
By Chas Newkey-Burden, The Week UK Published
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published